A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder

被引:31
|
作者
de Beaurepaire, Renaud [1 ]
机构
[1] Grp Hosp Paul Guiraud, Villejuif, France
来源
FRONTIERS IN PSYCHIATRY | 2018年 / 9卷
关键词
GABA receptor b; reward network; amygdala; Pavlovian associations; substitution; (morphine; methadone; buprenorphin); HIGH-DOSE BACLOFEN; VENTRAL TEGMENTAL AREA; GABA-B RECEPTOR; POSITIVE ALLOSTERIC MODULATOR; MESOLIMBIC DOPAMINE SYSTEM; TERM ABSTINENT ALCOHOLICS; RESTING-STATE SYNCHRONY; CENTRAL-NERVOUS-SYSTEM; PREFERRING SP RATS; BINGE-LIKE ETHANOL;
D O I
10.3389/fpsyt.2018.00506
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Baclofen, a GABA-B receptor agonist, is a promising treatment for alcohol use disorder (AUD). Its mechanism of action in this condition is unknown. GABA-B receptors interact with many biological systems potentially involved in AUD, including transduction pathways and neurotransmitter systems. Preclinical studies have shown that GABA-B receptors are involved in memory storage and retrieval, reward, motivation, mood and anxiety; neuroimaging studies in humans show that baclofen produces region-specific alterations in cerebral activity; GABA-B receptor activation may have neuroprotective effects; baclofen also has anti-inflammatory properties that may be of interest in the context of addiction. However, none of these biological effects fully explain the mechanism of action of baclofen in AUD. Data from clinical studies have provided a certain number of elements which may be useful for the comprehension of its mechanism of action: baclofen typically induces a state of indifference toward alcohol; the effective dose of baclofen in AUD is extremely variable from one patient to another; higher treatment doses correlate with the severity of the addiction; many of the side effects of baclofen resemble those of alcohol, raising the possibility that baclofen acts as a substitution drug; usually, however, there is no tolerance to the effects of baclofen during long-term AUD treatment. In the present article, the biological effects of baclofen are reviewed in the light of its clinical effects in AUD, assuming that, in many instances, clinical effects can be reliable indicators of underlying biological processes. In conclusion, it is proposed that baclofen may suppress the Pavlovian association between cues and rewards through an action in a critical part of the dopaminergic network (the amygdala), thereby normalizing the functional connectivity in the reward network. It is also proposed that this action of baclofen is made possible by the fact that baclofen and alcohol act on similar brain systems in certain regions of the brain.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Effects and Potential Mechanisms of Alcohol Use Disorder on the Fate Determination of Newly Born Neurons in the Hippocampus
    Shabani, Zahra
    Gharehziaaddin, Mohsen Jafarzadeh
    ALCOHOL AND ALCOHOLISM, 2020, 55 (06): : 598 - 602
  • [42] Baclofen, a French Exception, Seriously Harms Alcohol Use Disorder Patients Without Benefit
    Braillon, Alain
    Naudet, Florian
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (01)
  • [43] Response to 'acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?'
    Tyson, Luke D.
    Lewis, Heather
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (09) : 976 - 976
  • [44] Epigenetic Mechanisms Underlying Pathobiology of Alcohol Use Disorder
    Dulman, Russell S.
    Wandling, Gabriela M.
    Pandey, Subhash C.
    CURRENT PATHOBIOLOGY REPORTS, 2020, 8 (03) : 61 - 73
  • [45] Noradrenergic Mechanisms and Circuitry of Hyperkatifeia in Alcohol Use Disorder
    Varodayan, Florence P.
    Erikson, Chloe M.
    Scroger, Marcis V.
    Roberto, Marisa
    BIOLOGICAL PSYCHIATRY, 2025, 97 (06) : 580 - 589
  • [46] Circadian Mechanisms in Alcohol Use Disorder and Tissue Injury
    Davis, Booker T.
    Voigt, Robin M.
    Shaikh, Maliha
    Forsyth, Christopher B.
    Keshavarzian, Ali
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 (04) : 668 - 677
  • [47] Diagnosis and Pharmacotherapy of Alcohol Use Disorder A Review
    Kranzler, Henry R.
    Soyka, Michael
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (08): : 815 - 824
  • [48] Neuroimaging of inflammation in alcohol use disorder: a review
    Dana E.FELDMAN
    Katherine L.MCPHERSON
    Catherine L.BIESECKER
    Corinde E.WIERS
    Peter MANZA
    Nora D.VOLKOW
    Gene-Jack WANG
    ScienceChina(InformationSciences), 2020, 63 (07) : 19 - 37
  • [49] Neuroimaging of inflammation in alcohol use disorder: a review
    Dana E. Feldman
    Katherine L. McPherson
    Catherine L. Biesecker
    Corinde E. Wiers
    Peter Manza
    Nora D. Volkow
    Gene-Jack Wang
    Science China Information Sciences, 2020, 63
  • [50] The Prediction of Alcohol Use Disorder: A Scoping Review
    Ebrahimi, Ali
    Will, Uffe Kock
    Nielsen, Anette Sogaard
    Mansourvar, Marjan
    2019 IEEE SYMPOSIUM ON COMPUTERS AND COMMUNICATIONS (ISCC), 2019, : 1062 - 1067